Related references
Note: Only part of the references are listed.Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience
Ari Zimran et al.
BLOOD (2010)
Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry
Angela Dajnoki et al.
CLINICA CHIMICA ACTA (2010)
The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders
Arash Velayati et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2010)
Oropharyngeal Dysphagia in Infants and Children with Infantile Pompe Disease
Harrison N. Jones et al.
DYSPHAGIA (2010)
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
Priya S. Kishnani et al.
MOLECULAR GENETICS AND METABOLISM (2010)
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
Ans T. van der Ploeg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Metachromatic Leukodystrophy: A Scoring System for Brain MR Imaging Observations
F. Eichler et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Diffusion Tensor Imaging Detects Abnormalities in the Corticospinal Tracts of Neonates with Infantile Krabbe Disease
M. L. Escolar et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population
Hsiang-Yu Lin et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Implementation of newborn screening for Krabbe disease: Population study and cutoff determination
Joseph J. Orsini et al.
CLINICAL BIOCHEMISTRY (2009)
Development and Evaluation of Quality Control Dried Blood Spot Materials in Newborn Screening for Lysosomal Storage Disorders
Victor R. De Jesus et al.
CLINICAL CHEMISTRY (2009)
Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry
Stephen Waldek et al.
GENETICS IN MEDICINE (2009)
The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: Report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York
Patricia K. Duffner et al.
GENETICS IN MEDICINE (2009)
Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker
Sarah P. Young et al.
GENETICS IN MEDICINE (2009)
Management of neuronopathic Gaucher disease: Revised recommendations
A. Vellodi et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Recommendations on Diagnosis, Treatment, and Monitoring for Gaucher Disease
Ana Maria Martins et al.
JOURNAL OF PEDIATRICS (2009)
Bone Marrow Transplantation in Children with Hunter Syndrome: Outcome after 7 to 17 Years
Nathalie Guffon et al.
JOURNAL OF PEDIATRICS (2009)
Elimination of Antibodies to Recombinant Enzyme in Pompe's Disease
Nancy J. Mendelsohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme-A Preclinical and Phase I Investigation
David Aviezer et al.
PLOS ONE (2009)
Newborn Screening for Krabbe Disease: the New York State Model
Patricia K. Duffner et al.
PEDIATRIC NEUROLOGY (2009)
The Hunter's Hope Krabbe Family Database
Patricia K. Duffner et al.
PEDIATRIC NEUROLOGY (2009)
Pompe Disease in Infants: Improving the Prognosis by Newborn Screening and Early Treatment
Yin-Hsiu Chien et al.
PEDIATRICS (2009)
Mucopolysaccharidosis I: Management and Treatment Guidelines
Joseph Muenzer et al.
PEDIATRICS (2009)
Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options
Volkmar Gieselmann
ACTA PAEDIATRICA (2008)
Umbilical Cord Blood Transplantation for Juvenile Metachromatic Leukodystrophy
Tyler Mark Pierson et al.
ANNALS OF NEUROLOGY (2008)
Metachromatic leukodystrophy: an overview of current and prospective treatments
A. Biffi et al.
BONE MARROW TRANSPLANTATION (2008)
Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat
P. Mikosch et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy
Vanessa Goncalves Pereira et al.
CLINICA CHIMICA ACTA (2008)
Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model
A. Joseph et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Diagnosis of Metachromatic Leukodystrophy by Immune Quantification of Arylsulphatase A Protein and Activity in Dried Blood Spots
Mohd. A. F. Tan et al.
CLINICAL CHEMISTRY (2008)
Newborn screening for Pompe disease by measuring acid α-glucosidase activity using tandem mass spectrometry
Angela Dajnoki et al.
CLINICAL CHEMISTRY (2008)
Tandem Mass Spectrometry for the Direct Assay of Lysosomal Enzymes in Dried Blood Spots: Application to Screening Newborns for Mucopolysaccharidosis I
Sophie Blanchard et al.
CLINICAL CHEMISTRY (2008)
Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry
X. Kate Zhang et al.
CLINICAL CHEMISTRY (2008)
Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlation
A. Biffi et al.
CLINICAL GENETICS (2008)
Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study
K. B. Sims et al.
CLINICAL GENETICS (2008)
Putting the genetic information nondiscrimination act in context
Mark A. Rothstein
GENETICS IN MEDICINE (2008)
Legal update: living with the Genetic Information Nondiscrimination Act
Cheryl Erwin
GENETICS IN MEDICINE (2008)
Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report
N. Meuleman et al.
HAEMATOLOGICA (2008)
Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating
Marian Kroos et al.
HUMAN MUTATION (2008)
Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III
J. Cox-Brinkman et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring
T. M. Cox et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Cardiac involvement in adults with Pompe disease
O. I. I. Soliman et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease
Ozlem Goker-Alpan et al.
JOURNAL OF PEDIATRICS (2008)
Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities
N. A. M. E. van der Beek et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease
Gregory A. Grabowski
LANCET (2008)
Methods for a prompt and reliable laboratory diagnosis of Pompe disease: Report from an international consensus meeting
B. Winchester et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
William R. Wilcox et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease
P. Laforet et al.
NEUROLOGY (2008)
Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry
Robert J. Hopkin et al.
PEDIATRIC RESEARCH (2008)
Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience
Sadao Tokimasa et al.
PEDIATRIC TRANSPLANTATION (2008)
A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B
Margaret M. McGovern et al.
PEDIATRICS (2008)
Early detection of Pompe disease by newborn screening is feasible: Results from the Taiwan screening program
Yin-Hsiu Chien et al.
PEDIATRICS (2008)
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Johannes M. Aerts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Thrombotic complications of a basilar artery aneurysm in a young adult with Pompe disease
Daniel Refai et al.
SURGICAL NEUROLOGY (2008)
Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome
J. Tolar et al.
BONE MARROW TRANSPLANTATION (2008)
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
J. Edmond Wraith et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Non-neuronopathic Gaucher disease due to saposin C deficiency
Anna Tylki-Szymanska et al.
CLINICAL GENETICS (2007)
Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann-Pick type B
Jennifer Schneiderman et al.
PEDIATRIC BLOOD & CANCER (2007)
Pompe disease: Current state of treatment modalities and animal models
T. M. Geel et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance
Baodong Sun et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Unsuccessful treatment attempt: Cord blood stem cell transplantation in a patient with Niemann-Pick disease type A
C. F. Morel et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Newborn screening for Pompe disease: Synthesis of the evidence and development of screening recommendations
Alex R. Kemper et al.
PEDIATRICS (2007)
Outcome of type III Gaucher disease on enzyme replacement therapy: Review of 55 cases
E. H. Davies et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Late onset Pompe disease:: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients
Wolfgang Muller-Felber et al.
NEUROMUSCULAR DISORDERS (2007)
Mutational analysis of 105 mucopolysaccharidosis type VI patients
Litsa Karageorgos et al.
HUMAN MUTATION (2007)
Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study
Thomas Luecke et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2007)
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure
J. J. Boelens et al.
BONE MARROW TRANSPLANTATION (2007)
Effect of miglustat on bone disease in adults with type 1 Gaucher disease:: A pooled analysis of three multinational, open-label studies
Gregory M. Pastores et al.
CLINICAL THERAPEUTICS (2007)
Management guidelines for mucopolysaccharidosis VI
Roberto Giugliani et al.
PEDIATRICS (2007)
Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years:: Results of a multinational study of recombinant human α-L-iduronidase (Laronidase)
J. Edmond Wraith et al.
PEDIATRICS (2007)
Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy - A retrospective analysis from the Fabry outcome survey
Bjoern Hoffmann et al.
CLINICAL JOURNAL OF PAIN (2007)
Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase/miglustat combination
Jose L. Capablo et al.
EPILEPSIA (2007)
Sustained, long-term renal stabilization after 54 months of agalsidase β therapy in patients with Fabry disease
Dominique P. Germain et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Mucopolysaccharidosis type II: an update on mutation spectrum
Roseline Froissart et al.
ACTA PAEDIATRICA (2007)
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
C. Sevin et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease
H. Church et al.
BONE MARROW TRANSPLANTATION (2007)
Recombinant human acid α-glucosidase -: Major clinical benefits in infantile-onset Pompe disease
P. S. Kishnani et al.
NEUROLOGY (2007)
Broad spectrum of Pompe disease in patients with the same c.-32-13T→G haplotype
M. A. Kroos et al.
NEUROLOGY (2007)
Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease
Derralynn Hughes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression
R. G. M. Bredius et al.
BONE MARROW TRANSPLANTATION (2007)
Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life
Raymond Y. Wang et al.
GENETICS IN MEDICINE (2007)
Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease
Tokiko Fukuda et al.
MOLECULAR THERAPY (2006)
Acid sphingomyelinase deficiency: Prevalence and characterization of an intermediate phenotype of NIEMANN-PICK disease
Melissa P. Wasserstein et al.
JOURNAL OF PEDIATRICS (2006)
Late-onset metachromatic leukodystrophy - Genotype strongly influences phenotype
H. Rauschka et al.
NEUROLOGY (2006)
Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy
Yin-Hsiu Chien et al.
PEDIATRIC RESEARCH (2006)
Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease
Markus Ries et al.
PEDIATRICS (2006)
Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease
Gregory Bierer et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Newborn screening for lysosomal storage disorders
Peter J. Meikle et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Peripheral neuropathy in Krabbe disease - Electrodiagnostic findings
Zaeem A. Siddiqi et al.
NEUROLOGY (2006)
Detection of hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: Biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers
Shuan-Pei Lin et al.
CLINICA CHIMICA ACTA (2006)
High incidence of later-onset Fabry disease revealed by newborn screening
Marco Spada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe disease
Priya Sunil Kishnani et al.
JOURNAL OF PEDIATRICS (2006)
Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome
J. Cox-Brinkman et al.
BONE MARROW TRANSPLANTATION (2006)
Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation
Chengzhe Xu et al.
JOURNAL OF HUMAN GENETICS (2006)
Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid α-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease
Haoyue Zhang et al.
GENETICS IN MEDICINE (2006)
Pompe disease diagnosis and management guideline
Priya S. Kishnani et al.
GENETICS IN MEDICINE (2006)
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease
Priya S. Kishnani et al.
JOURNAL OF PEDIATRICS (2006)
Diagnostic challenges for Pompe disease: An under-recognized cause of floppy baby syndrome
RR Howell et al.
GENETICS IN MEDICINE (2006)
Ambulatory electrocardiogram analysis in infants treated with recombinant human acid α-glucosidase enzyme replacement therapy for Pompe disease
Amanda L. Cook et al.
GENETICS IN MEDICINE (2006)
Disease manifestations and X inactivation in heterozygous females with Fabry disease
Esther M. Maier et al.
ACTA PAEDIATRICA (2006)
Enzyme replacement therapy for mucopolysaccharidosis VI: A Phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
Paul Harmatz et al.
JOURNAL OF PEDIATRICS (2006)
Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders
Michael H. Gelb et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Natural history of type a Niemann-Pick disease - Possible endpoints for therapeutic trials
MM McGovern et al.
NEUROLOGY (2006)
Clinical manifestations of Fabry disease in children: Data from the Fabry outcome survey
U Ramaswami et al.
ACTA PAEDIATRICA (2006)
NICHD research initiative in newborn screening
Duane Alexander et al.
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2006)
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement
Christine M. Eng et al.
GENETICS IN MEDICINE (2006)
Cumulative incidence rates of the mucopolysaccharidoses in Germany
F Baehner et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Prevalence of Fabry disease in patients with cryptogenic stroke:: a prospective study
A Rolfs et al.
LANCET (2005)
Successful hematopoietic stem cell transplantation for Niemann-Pick disease type B
AJ Shah et al.
PEDIATRICS (2005)
The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease a cross-sectional study of a large cohort of clinically affected heterozygous women
S Gupta et al.
MEDICINE (2005)
Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II
T Kato et al.
JOURNAL OF HUMAN GENETICS (2005)
The natural course of non-classic Pompe's disease; a review of 225 published cases
LPF Winkel et al.
JOURNAL OF NEUROLOGY (2005)
Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease
Y An et al.
MOLECULAR GENETICS AND METABOLISM (2005)
An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum
DA Brooks et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Gaucher disease and cancer incidence: a study from the Gaucher Registry
BE Rosenbloom et al.
BLOOD (2005)
Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease
ML Escolar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mucopolysaccharidosis type II in females: Case report and review of literature
K Tuschl et al.
PEDIATRIC NEUROLOGY (2005)
Natural history of the cerebrovascular complications of Fabry disease
A Mehta et al.
ACTA PAEDIATRICA (2005)
Vascular complications of Fabry disease: enzyme replacement and other therapies
DA Hughes et al.
ACTA PAEDIATRICA (2005)
Lysosomal acid α-glucosidase consists of four different peptides processed from a single chain precursor
RJ Moreland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome
SS Grewal et al.
GENETICS IN MEDICINE (2005)
Fabry disease in patients with end-stage renal failure: The potential benefits of screening
S Bekri et al.
NEPHRON CLINICAL PRACTICE (2005)
Cardiopulmonary exercise testing in Fabry disease
G Bierer et al.
RESPIRATION (2005)
Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study
H Pavlu-Pereira et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Results of a nationwide screening for Anderson-Fabry disease among dialysis patients
P Kotanko et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
P Harmatz et al.
JOURNAL OF PEDIATRICS (2004)
Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements
GA Grabowski et al.
EUROPEAN JOURNAL OF PEDIATRICS (2004)
Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper
NA Chamoles et al.
CLINICA CHIMICA ACTA (2004)
Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C
RH Lachmann et al.
NEUROBIOLOGY OF DISEASE (2004)
The natural history of type B Niemann-Pick disease: Results from a 10-year longitudinal study
MP Wasserstein et al.
PEDIATRICS (2004)
Enzyme replacement therapy for Fabry disease:: lessons from two α-galactosidase A orphan products and one FDA approval
RJ Desnick
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases
W Krivit
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2004)
Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse
JHJ Kamphoven et al.
NEUROBIOLOGY OF DISEASE (2004)
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention
RG Boot et al.
BLOOD (2004)
Gaucher disease type 1:: Revised recommendations on evaluations and monitoring for adult patients
NJ Weinreb et al.
SEMINARS IN HEMATOLOGY (2004)
Cord-blood transplants from unrelated donors in patients with Hurler's syndrome
SL Staba et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Enzyme replacement therapy for mucopolysaccharidosis I:: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (Laronidase)
JE Wraith et al.
JOURNAL OF PEDIATRICS (2004)
Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening
YJ Li et al.
CLINICAL CHEMISTRY (2004)
Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease
D Elstein et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2004)
Relief of gastrointestinal symptoms under enzyme replacement therafpy in patients with Fabry disease
F Dehout et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2004)
Incidence of the mucopolysaccharidoses in Western Australia
J Nelson et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)
Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease - A prospective strain rate imaging study
F Weidemann et al.
CIRCULATION (2003)
Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a renal variant phenotype
S Nakao et al.
KIDNEY INTERNATIONAL (2003)
The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature
HMP van den Hout et al.
PEDIATRICS (2003)
Postischemic cutaneous hyperperfusion in the presence of forearm hypoperfusion suggests sympathetic vasomotor dysfunction in Fabry disease
B Stemper et al.
JOURNAL OF NEUROLOGY (2003)
Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature
NJ Terlato et al.
GENETICS IN MEDICINE (2003)
Human gene mutation database (HGMD®):: 2003 update
PD Stenson et al.
HUMAN MUTATION (2003)
Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources
G Souillet et al.
BONE MARROW TRANSPLANTATION (2003)
PR interval and the response to enzyme-replacement therapy for Fabry's disease
S Waldek
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function
G De Schoenmakere et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Niemann-Pick disease: Sixteen-year follow-up of allogeneic bone marrow transplantation in a type B variant
S Victor et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2003)
Use of gabapentin to reduce chronic neuropathic pain in Fabry disease
M Ries et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2003)
Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study
F Baehner et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2003)
Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients
U Matte et al.
MOLECULAR GENETICS AND METABOLISM (2003)
The status of hematopoietic stem cell transplantation in lysosomal storage disease
JJ Malatack et al.
PEDIATRIC NEUROLOGY (2003)
Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma
R Froissart et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Fabry disease: Characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele
M Yasuda et al.
HUMAN MUTATION (2003)
Enzyme therapy of Gaucher disease: clinical and biochemical changes during production of and tolerization for neutralizing antibodies
HQ Zhao et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
The demographics and distribution of type B Niemann-Pick disease: Novel mutations lead to new genotype/phenotype correlations
CM Simonaro et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
ON Koç et al.
BONE MARROW TRANSPLANTATION (2002)
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy
B Sachdev et al.
CIRCULATION (2002)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease.
CM Eng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Enzyme replacement therapy in Fabry disease - A randomized controlled trial
R Schiffmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prenatal genetic screening in the Ashkenazi Jewish population
RE Zinberg et al.
CLINICS IN PERINATOLOGY (2001)
Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry
PD Whitfield et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II:: Results of a phase I/II clinical trial
A Amalfitano et al.
GENETICS IN MEDICINE (2001)
A phase 1/2 clinical trial of enzyme replacement in Fabry disease: Pharmacokinetic, substrate clearance, and safety studies
CM Eng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Enzyme-replacement therapy in mucopolysaccharidosis I.
ED Kakkis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Umbilical cord blood transplantation for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)
V Lee et al.
BONE MARROW TRANSPLANTATION (2000)
Recombinant human α-glucosidase from rabbit milk in Pompe patients
H Van den Hout et al.
LANCET (2000)
Krabbe disease: Genetic aspects and progress toward therapy
DA Wenger et al.
MOLECULAR GENETICS AND METABOLISM (2000)
Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia
CA Mullen et al.
BONE MARROW TRANSPLANTATION (2000)
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis
T Cox et al.
LANCET (2000)
Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease
R Schiffmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
